Skip to main content
Log in

Haemodynamic Changes Associated with Long Term Antihypertensive Therapy with Ketanserin

  • Short Communication
  • Poster Presentations: Clinical Pharmacology
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Buckingham RE, Hamilton TC, Robson D. Effect of intracerebroventricular 5,6-dihydroxytryptamine on blood pressure of spontaneously hypertensive rats. European Journal of Pharmacology 36: 431–437, 1976

    Article  CAS  PubMed  Google Scholar 

  • De Clerck F, Jageneau A, Dom J. Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs. Archives Internationales de Pharmacodynamic et de Thérapie 258: 100–115, 1982

    Google Scholar 

  • Fujita T, Sato Y, Ando K, Noda H, Ueno N, et al. Dynamic responses of active and inactive renin and plasma norepinephrine during exercise in normal man. Japanese Heart Journal 23: 545–551, 1982a

    Article  CAS  PubMed  Google Scholar 

  • Fujita T, Ando K, Noda H, Sato Y, Yamashita N, et al. Hemodynamic and endocrine changes associated with Captopril in diuretic-resistant hypertensive patients. American Journal of Medicine 73: 341–347, 1982b

    Article  CAS  PubMed  Google Scholar 

  • Hedner T, Pettersson A, Persson B. Blood pressure reduction and pharmacokinetics of ketanserin in patients with essential hypertension. Satellite symposium to the 2nd European Meeting on Hypertension, Milan, June 9, 1985. Abstract, p. 35, 1985

  • Janssen PAJ. 5-HT2 receptor blockade to study serotonin-induced pathology. Trends in Pharmacological Sciences 4: 198–206, 1983

    Article  CAS  Google Scholar 

  • Jarrott B, McQueen A, Graf L, Louis WJ. Serotonin levels in vascular tissue and the effects of a serotonin synthesis inhibitor on blood pressure in hypertensive rats. Clinical and Experimental Pharmacology and Physiology (Suppl. 2): 201–205, 1975

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, et al. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sciences 28: 1015–1022, 1981

    Article  CAS  PubMed  Google Scholar 

  • Noda H, Fujita T. Left ventricular hypertrophy in young patients with borderline hypertension. Nippon Naika Gakkai Zasshi (Journal of the Japanese Society of Internal Medicine) 76: 1211–1217, 1987

    Article  CAS  Google Scholar 

  • Pettersson A, Gradin K, Hedner T, Persson ?. Antihypertensive mechanism of action of ketanserin and some ketanserin dialogues in the spontaneously hypertensive rat. Naunyn-Schmiedeberg’s Archives of Pharmacology 329: 394–397, 1985

    Article  CAS  PubMed  Google Scholar 

  • Schalekamp MADH. Haemodynamic effects of ketanserin: mechanism of the antihypertensive action. Satellite symposium to the 2nd European Meeting on Hypertension, Milan, June 9, 1985. Abstract, p. 9, 1985

  • Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noda, H., Isaka, M., Ito, Y. et al. Haemodynamic Changes Associated with Long Term Antihypertensive Therapy with Ketanserin. Drugs 36 (Suppl 1), 115–119 (1988). https://doi.org/10.2165/00003495-198800361-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00022

Keywords

Navigation